The FDA has finalized guidance on decentralized clinical trials (DCTs) as AI and data science tools gain traction in drug development. The updated ICH E6(R3) Good Clinical Practice guideline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results